Boston Scientific Corp (BSX):企業の財務・戦略的SWOT分析

◆英語タイトル:Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15276
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Boston Scientific Corp (BSX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Boston Scientific Corp (Boston Scientific) is a medical device company that develops, manufactures and markets devices used in a range of interventional medical procedures. The company offers products used in the areas of interventional cardiology, cardiac rhythm management (CRM), peripheral interventions, electrophysiology, endoscopy, urology, pelvic health and neuromodulation. The company markets its products to hospitals, clinics, outpatient facilities and medical offices worldwide. It has several manufacturing, distribution and technology centers worldwide. The company markets its products through direct sales organizations and a network of distributors and dealers in Europe, the Middle East, Africa, Asia-Pacific and the Americas. Boston Scientific is headquartered in Marlborough, Massachusetts, the US.

Boston Scientific Corp Key Recent Developments

Feb 15,2019: BRAVO BIDCO: Update on the proposed acquisition of BTG
Feb 06,2019: Boston Scientific announces results for fourth quarter and full year 2018
Feb 01,2019: Boston Scientific joins Worcester Polytechnic Institute’s practicepoint medical technologies research & development center
Jan 31,2019: Boston Scientific Launches Spectra WaveWriter™ Spinal Cord Stimulator System in Europe
Jan 24,2019: Boston Scientific introduces Vercise primary cell and Vercise Gevia deep brain stimulation systems with directional leads

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Boston Scientific Corp – Key Facts
Boston Scientific Corp – Key Employees
Boston Scientific Corp – Key Employee Biographies
Boston Scientific Corp – Major Products and Services
Boston Scientific Corp – History
Boston Scientific Corp – Company Statement
Boston Scientific Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Boston Scientific Corp – Business Description
Business Segment: Cardiovascular
Overview
Performance
Business Segment: MedSurg
Overview
Performance
Business Segment: Rhythm and Neuro
Overview
Performance
Geographical Segment: APAC (Asia-Pacific)
Performance
Geographical Segment: EMEA (Europe, Middle East and Africa)
Performance
Geographical Segment: LACA (Latin America and Canada)
Performance
Geographical Segment: U.S.
Performance
R&D Overview
Boston Scientific Corp – Corporate Strategy
Boston Scientific Corp – SWOT Analysis
SWOT Analysis – Overview
Boston Scientific Corp – Strengths
Boston Scientific Corp – Weaknesses
Boston Scientific Corp – Opportunities
Boston Scientific Corp – Threats
Boston Scientific Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Boston Scientific Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Boston Scientific Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Boston Scientific Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG
Feb 06, 2019: Boston Scientific announces results for fourth quarter and full year 2018
Feb 01, 2019: Boston Scientific joins Worcester Polytechnic Institute’s practicepoint medical technologies research & development center
Jan 31, 2019: Boston Scientific Launches Spectra WaveWriter™ Spinal Cord Stimulator System in Europe
Jan 24, 2019: Boston Scientific introduces Vercise primary cell and Vercise Gevia deep brain stimulation systems with directional leads
Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Jan 21, 2019: Viva physicians to lead pan-industry collaboration to further evaluate the use of paclitaxel drug-eluting technologies in PAD
Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement
Jan 08, 2019: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Boston Scientific Corp, Key Facts
Boston Scientific Corp, Key Employees
Boston Scientific Corp, Key Employee Biographies
Boston Scientific Corp, Major Products and Services
Boston Scientific Corp, History
Boston Scientific Corp, Other Locations
Boston Scientific Corp, Subsidiaries
Boston Scientific Corp, Key Competitors
Boston Scientific Corp, Ratios based on current share price
Boston Scientific Corp, Annual Ratios
Boston Scientific Corp, Annual Ratios (Cont...1)
Boston Scientific Corp, Annual Ratios (Cont...2)
Boston Scientific Corp, Interim Ratios
Boston Scientific Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Boston Scientific Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Boston Scientific Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Boston Scientific Corp, Performance Chart (2014 - 2018)
Boston Scientific Corp, Ratio Charts
Boston Scientific Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Boston Scientific Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Boston Scientific Corp (BSX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Immunovia AB (IMMNOV):企業の製品パイプライン分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Bukwang Pharmaceutical Co Ltd (003000):企業の財務・戦略的SWOT分析
    Summary Bukwang Pharmaceutical Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexide, chioctaside, levovir, orfil, lonacene, axima, and excel, among others. Its pipeline products comprise JM-0 …
  • Allergan plc:企業のM&A・事業提携・投資動向
    Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Canada Pension Plan Investment Board:企業の戦略・SWOT・財務情報
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • CITIC Resources Holdings Limited:企業の戦略・SWOT・財務情報
    CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Aptech Ltd (APTECHT):企業の財務・戦略的SWOT分析
    Aptech Ltd (APTECHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pabst Brewing Company:企業の戦略・SWOT・財務分析
    Pabst Brewing Company - Strategy, SWOT and Corporate Finance Report Summary Pabst Brewing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Physiomics Plc (PYC):製薬・医療:M&Aディール及び事業提携情報
    Summary Physiomics plc (Physiomics) is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in pre-clinical trials, cardiac toxicity services through its EasyAP, a Web-based simulation and analysis tool. It also offer …
  • Daybreak Oil and Gas Inc (DBRM):石油・ガス:M&Aディール及び事業提携情報
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Lockton, Inc:企業の戦略・SWOT・財務情報
    Lockton, Inc - Strategy, SWOT and Corporate Finance Report Summary Lockton, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include QUANTA Flash used for semi-quantitative determination of aut …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose), formerly Wheelmark Plc is an investment company that offers buy, improve and sell manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipments. Its business portfo …
  • National Beverage Corp. (FIZZ):企業の財務・戦略的SWOT分析
    National Beverage Corp. (FIZZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆